G
Gleamer
Biotech & Life Sciences · Saint-Mandé, France · Founded 2017
Providing imaging users a suite of Artificial Intelligence solutions covering a wide range of clinical applications MoreLess
GLEAMER is a French company founded in 2017 by Christian Allouche and Alexis Ducarouge. The company develops and markets artificial intelligence-powered software for medical imaging, specifically for radiology.
The company's main product is BoneView, a software that uses AI to detect fractures in X-ray images. BoneView is designed to be used by radiologists and emergency physicians to help them make more accurate and efficient diagnoses. The software is CE-marked and has received FDA clearance in the United States.
In addition to BoneView, GLEAMER also offers ChestView, a software that helps detect pulmonary pathologies in chest X-rays.
GLEAMER's business model is based on a subscription fee for its software. The company targets hospitals, clinics, and teleradiology companies as its primary customers.
Keywords: medical imaging, radiology, artificial intelligence, fracture detection, diagnostic aid, CE mark, FDA clearance, BoneView, ChestView, teleradiology.
Company overview
Gleamer company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2017
- Headquarters
- Saint-Mandé, France
- Employees
- 125
- Open positions
- 3
- Dealroom signal
- 83.0
- Investment activity
- 2 companies · latest Mar 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Gleamer funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2026 | $230M | — | RadNet | ↗ |
| GRANT✓Other financing | Dec 2024 | $5M | — | French Government | ↗ |
| SERIES B✓Equity / VC | Jun 2023 | $30M | $119M | Elaia · UI Investissement · Crista Galli Ventures · MACSF | ↗ |
| SERIES A✓Equity / VC | Sep 2020 | $8.3M | $33M | Majycc eSanté Invest · MACSF · Elaia · XAnge | ↗ |
| SUPPORT PROGRAM✓Other financing | Nov 2019 | $55K | — | EIT Health | — |
| SEED✓Equity / VC | Sep 2018 | Bpifrance · XAnge · Elaia | ↗ |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $33M | +188.5% | 124 |
| 2025 | $11M | -48% | 123 |
| 2024 | $22M | +66.7% | 90 |
| 2023 | $13M | +150% | 80 |
| 2022 | $5.3M | +140% | 62 |
| 2021 | $2.2M | +100% | 41 |
| 2020 | $1.1M | — | 24 |
Growth signals
Gleamer website traffic
Latest recorded traffic for Gleamer is 10K monthly website visits, down 23.1% over the last three months. Gleamer's team grew 1.6% over the past year.
Hiring
Open positions at Gleamer
Current openings linked to this company in Dealroom.
Comparisons
Gleamer compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Gleamer investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Caerus MedicalLoos, FranceBring to caregivers digital spine solutions for optimal patient pathways
→
PixylLa Tronche, FranceNeuroimaging AI for Improved Patient Care
$9.7Mvaluation
Talent graph
Gleamer's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Gleamer has talent and traffic
team presence
In the news
Latest news about Gleamer
Recent press, funding announcements, and product moves mentioning Gleamer — open to read from the original sources.
Market sentiment
What the market is saying about Gleamer
An AI-synthesized read of the highest-engagement posts about Gleamer on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Gleamer’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.